Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Mineralys Therapeutics (MLYS)

Annual Return

Over the past 3 years, MLYS has had an average annual return of +22.17%, outperforming the benchmark SPY, which returned +19.62% annual.

Since Feb 10, 2023, MLYS has had an average annual return of +12.33%, underperforming the benchmark SPY, which returned +20.82% annual.

2026202520242023
-24.17%+194.79%+43.14%-53.36%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-14.88%-5.28%-7.42%-1.63%+18.20%-14.35%+2%-24.17%
2025-16.33%-11.26%+73.73%-10.52%+9.64%-13.16%+4.59%+9.40%+144.96%+7.75%+5.53%-15.84%+194.79%
2024+26.84%+40.99%-16.07%-5.11%+4.25%-8.38%+5.89%+0.16%-2.42%+10.49%-4.56%-3.60%+43.14%
2023-3.58%-11.93%-14.11%+8.10%+17.26%-17.12%-9.13%-25.94%-18.71%-13.84%+29.13%-53.36%

Drawdown analysis of Mineralys Therapeutics (MLYS)

The maximum drawdown for the MLYS was -68.86%, occurring on Nov 22, 2023. Recovery took 443 trading sessions.

The current MLYS drawdown is -41.86%.

Since Feb 10, 2023 MLYS has experienced the following drawdowns:

  • 50% or more: 2 times
  • 40% or more: 2 times
  • 30% or more: 2 times
  • 20% or more: 2 times
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-68.86%Mar 3, 2023183Nov 22, 2023443Sep 2, 2025626
-52.46%Nov 12, 2025141Jun 8, 2026OngoingOngoingOngoing
-16.19%Oct 20, 202513Nov 6, 20252Nov 10, 202515
-7.60%Feb 13, 20239Feb 27, 20234Mar 3, 202313
-7.35%Oct 2, 20254Oct 8, 20252Oct 10, 20256
-6.09%Sep 10, 20253Sep 15, 20253Sep 18, 20256
-5.56%Sep 18, 20253Sep 23, 20253Sep 26, 20256
-5.18%Sep 26, 20252Sep 30, 20252Oct 2, 20254
-0.88%Oct 15, 20251Oct 16, 20251Oct 17, 20252
-0.58%Oct 13, 20251Oct 14, 20251Oct 15, 20252